See more : Evercore Inc. (EVR) Income Statement Analysis – Financial Results
Complete financial analysis of DIO Corporation (039840.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DIO Corporation, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Metalex Ventures Ltd. (MXTLF) Income Statement Analysis – Financial Results
- S.A.F. Special Steel Public Company Limited (SAF.BK) Income Statement Analysis – Financial Results
- Vestate Group Holdings Limited (1386.HK) Income Statement Analysis – Financial Results
- SBEC SYSTEMS (INDIA) LTD. (SBECSYS.BO) Income Statement Analysis – Financial Results
- Yunnan Yunwei Company Limited (600725.SS) Income Statement Analysis – Financial Results
DIO Corporation (039840.KQ)
About DIO Corporation
DIO Corporation manufactures and sells dental implants in South Korea. It offers implant systems, which include UFII int. submerged and no-submerged systems, FTN external systems, protem mini systems, UV active and activators, and instrument kits. The company also provides dental digital solutions and dental products; and cardiovascular medical devices. In addition, it exports its products to approximately 70 countries. The company was formerly known as DSI Co., Ltd and changed its name to DIO Corporation in August 2008. DIO Corporation was founded in 1988 and is headquartered in Busan, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 155.82B | 131.31B | 150.04B | 120.06B | 127.17B | 91.04B | 91.92B | 88.02B | 71.94B | 61.58B | 62.79B | 47.87B |
| Cost of Revenue | 42.71B | 50.15B | 49.18B | 41.88B | 37.91B | 32.27B | 31.30B | 31.64B | 30.89B | 29.02B | 32.44B | 18.19B |
| Gross Profit | 113.11B | 81.15B | 100.86B | 78.18B | 89.26B | 58.77B | 60.62B | 56.38B | 41.05B | 32.55B | 30.35B | 29.68B |
| Gross Profit Ratio | 72.59% | 61.80% | 67.22% | 65.12% | 70.19% | 64.55% | 65.94% | 64.06% | 57.07% | 52.87% | 48.34% | 62.00% |
| Research & Development | 3.83B | 3.90B | 2.78B | 1.98B | 2.83B | 2.82B | 2.57B | 2.23B | 1.58B | 1.44B | 1.96B | 2.07B |
| General & Administrative | 8.05B | 7.96B | 5.82B | 4.33B | 455.57M | 615.50M | 786.51M | 363.89M | 235.45M | 352.20M | 347.53M | 228.59M |
| Selling & Marketing | 13.24B | 14.54B | 10.28B | 5.66B | 8.31B | 9.01B | 7.93B | 5.93B | 3.20B | 6.10B | 7.06B | 4.01B |
| SG&A | 21.29B | 81.48B | 62.27B | 45.12B | 53.32B | 47.17B | 35.37B | 26.92B | 17.58B | 26.79B | 29.43B | 21.84B |
| Other Expenses | 67.09B | -2.29B | -1.35B | -1.05B | -1.01B | -699.60M | -626.79M | -622.22M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 92.21B | 87.67B | 66.41B | 48.15B | 57.15B | 50.68B | 38.57B | 29.77B | 22.52B | 29.07B | 33.74B | 29.75B |
| Cost & Expenses | 134.92B | 137.82B | 115.58B | 90.03B | 95.06B | 82.96B | 69.87B | 61.41B | 53.41B | 58.10B | 66.18B | 47.94B |
| Interest Income | 257.30M | 149.34M | 80.57M | 83.99M | 318.85M | 1.72B | 1.14B | 587.32M | 5.49B | 7.46B | 6.63B | 5.92B |
| Interest Expense | 7.72B | 5.00B | 3.97B | 3.25B | 2.36B | 1.86B | 1.21B | 665.51M | 5.57B | 7.49B | 6.66B | 6.00B |
| Depreciation & Amortization | 12.31B | 13.17B | 11.42B | 9.54B | 8.84B | 5.84B | 4.04B | 2.88B | 2.22B | 2.32B | 1.88B | 1.64B |
| EBITDA | 30.44B | -2.80B | 49.69B | 29.52B | 41.36B | 13.98B | 18.71B | 29.11B | 22.60B | 4.67B | -661.48M | 6.32B |
| EBITDA Ratio | 19.53% | 5.07% | 30.57% | 32.96% | 32.20% | 15.30% | 28.38% | 33.51% | 30.81% | 7.58% | -1.05% | 13.21% |
| Operating Income | 20.90B | -6.52B | 34.45B | 30.03B | 32.11B | 8.08B | 22.05B | 26.61B | 19.95B | 2.35B | -2.54B | 4.68B |
| Operating Income Ratio | 13.41% | -4.96% | 22.96% | 25.01% | 25.25% | 8.88% | 23.99% | 30.24% | 27.73% | 3.82% | -4.04% | 9.78% |
| Total Other Income/Expenses | -10.49B | -14.56B | -641.87M | -13.28B | -4.61B | -1.80B | -8.58B | -1.04B | -6.91B | -6.33B | -5.82B | -8.31B |
| Income Before Tax | 10.41B | -20.97B | 34.30B | 16.73B | 30.16B | 6.28B | 13.46B | 25.56B | 13.04B | -3.98B | -10.02B | -5.99B |
| Income Before Tax Ratio | 6.68% | -15.97% | 22.86% | 13.93% | 23.72% | 6.90% | 14.65% | 29.04% | 18.12% | -6.46% | -15.96% | -12.51% |
| Income Tax Expense | 7.79B | -968.12M | 5.69B | 5.08B | 9.80B | -904.92M | 3.81B | 4.63B | 3.98B | 274.83M | 1.63B | 1.88B |
| Net Income | 3.31B | -20.46B | 28.25B | 11.15B | 21.73B | 5.45B | 8.56B | 20.51B | 9.25B | -3.61B | -8.27B | -4.11B |
| Net Income Ratio | 2.13% | -15.58% | 18.83% | 9.29% | 17.09% | 5.99% | 9.31% | 23.31% | 12.86% | -5.86% | -13.17% | -8.58% |
| EPS | 227.00 | -1.38K | 1.93K | 758.93 | 1.48K | 379.08 | 595.42 | 1.41K | 751.00 | -319.00 | -731.00 | -364.00 |
| EPS Diluted | 227.46 | -1.38K | 1.93K | 758.93 | 1.48K | 379.08 | 595.42 | 1.41K | 751.00 | -319.00 | -731.00 | -364.00 |
| Weighted Avg Shares Out | 14.59M | 14.82M | 14.63M | 14.70M | 14.66M | 14.39M | 14.37M | 14.55M | 12.32M | 11.32M | 11.31M | 11.29M |
| Weighted Avg Shares Out (Dil) | 14.56M | 14.82M | 14.63M | 14.70M | 14.66M | 14.39M | 14.37M | 14.55M | 12.32M | 11.32M | 11.31M | 11.29M |
Source: https://incomestatements.info
Category: Stock Reports